FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to obstetrics and anesthesiology. Patient, 1–5 days prior to delivery, is administered oral intake of vitamin D of 10,000 IU per day, Ca-based medication – 1.5 g/day, magnesium orotate – 3,000 mg/day. With moderate preeclampsia, drugs are taken within 3–5 days, and with severe eclampsia – within 1–2 days.
EFFECT: method makes it possible to prevent the harmful effects of drugs used for epidural anesthesia in women with preeclampsia or the possibility of developing preeclampsia in patients with a burdened obstetric history.
1 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING PREECLAMPSIA IN PATIENTS WITH AN AGGRAVATED OBSTETRIC ANAMNESIS | 2016 |
|
RU2663593C2 |
| METHOD OF ANALGESIC DELIVERY | 2018 |
|
RU2711534C1 |
| METHOD OF BIRTH COMPLICATIONS PREVENTION IN WOMEN WITH CONTRACTED PELVIS | 2009 |
|
RU2403920C1 |
| METHOD FOR PREVENTING PLACENTAL DEFICIENCY UNDER CONDITIONS OF UROGENITAL INFECTING WITH CHLAMYDIOSIS | 2004 |
|
RU2268740C1 |
| METHOD FOR DELIVERY IN PATIENTS WITH GESTOSIS AT THE SECOND HALF OF PREGNANCY | 2003 |
|
RU2243003C1 |
| METHOD FOR PREVENTION OF PREECLAMPSIA IN CARRIERS OF F2G20210A MUTATION WITH SUPERTHRESHOLD INCREASE OF PROTHROMBIN ACTIVITY | 2019 |
|
RU2712444C1 |
| METHOD OF ANESTHESIA AFTER CARRYING OUT CESAREAN SECTION OPERATIONS IN PATIENTS WITH EXCESSIVE BODY MASS | 2017 |
|
RU2649961C1 |
| METHOD OF PREDICTING PRE-TERM LABOUR IN PATIENTS WITH PRIMARY RECURRENT MISCARRIAGE | 2012 |
|
RU2485896C1 |
| METHOD FOR ANESTHESIOLOGICAL PROVISION OF OPEN OPERATIONS ON THE FETUS FOR CORRECTION OF SPINA BIFIDA | 2022 |
|
RU2789590C1 |
| METHOD FOR COAGULOPATIC BLEEDING PREVENTION DURING CESAREAN SECTION | 2016 |
|
RU2629040C1 |
